Von Eschenbach Nomination To Head FDA Already Mired In “Plan B” Politics
This article was originally published in The Gray Sheet
Executive Summary
No sooner did President Bush nominate Acting FDA Commissioner Andrew von Eschenbach March 15 to permanently head the agency than Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) announced they would place a hold on the nomination
You may also be interested in...
Plan B Backlash Blocks FDA Commissioner Nomination, Take Two
FDA will not have a permanent commissioner until a decision is announced on over-the-counter sales of Barr's emergency contraceptive Plan B, if a hold by Senate Democrats is respected
Plan B Backlash Blocks FDA Commissioner Nomination, Take Two
FDA will not have a permanent commissioner until a decision is announced on over-the-counter sales of Barr's emergency contraceptive Plan B, if a hold by Senate Democrats is respected
Senate Confirms Crawford As FDA Commissioner In 78-16 Vote
Lester Crawford's nomination to be FDA's permanent commissioner cleared the Senate July 18 by a vote of 78-16